INTERNATIONAL PATENT: CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD., 成都倍特药业股份有限公司 FILES APPLICATION FOR "OLIGONUCLEOTIDE FOR INHIBITING HEPATITIS B VIRUS, CONJUGATE, COMPOSITION AND USE THEREOF"

GENEVA, Nov. 17 -- CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. (No. 263, Hexiang 3rd Street, High-tech Zone,Chengdu, Sichuan 610041), 成都倍特药业股份有限公司 (中国四川省成都市高新区和祥三街263号) filed a patent application (PCT/CN2025/093826) for "OLIGONUCLEOTIDE FOR INHIBITING HEPATITIS B VIRUS, CONJUGATE, COMPOSITION AND USE THEREOF" on May 09, 2025. With publication no. WO/2025/232886, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which ...